4.6 Article

C-Reactive Protein Levels in African Americans A Diet and Lifestyle Randomized Community Trial

期刊

AMERICAN JOURNAL OF PREVENTIVE MEDICINE
卷 45, 期 4, 页码 430-440

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amepre.2013.05.011

关键词

-

资金

  1. National Cancer Institute, National Institute on Minority Health and Health Disparities (NIMHD) [R24 MD002769]
  2. Cancer Training Branch of the National Cancer Institute [K05 CA136975]
  3. Cancer Education and Career Development Program Grant [R25 CA090956]

向作者/读者索取更多资源

Background: Chronic inflammation is linked to poor lifestyle behaviors and a variety of chronic diseases that are prevalent among African Americans, especially in the southeastern U.S. Purpose: The goal of the study was to test the effect of a community-based diet, physical activity, and stress reduction intervention conducted in 2009-2012 on reducing serum C-reactive protein (CRP) in overweight and obese African-American adults. Methods: An RCT intervention was designed jointly by members of African-American churches and academic researchers. In late 2012, regression (i.e., mixed) models were fit that included both intention-to-treat and post hoc analyses conducted to identify important predictors of intervention success. Outcomes were assessed at 3 months and 1 year. Results: At baseline, the 159 individuals who were recruited in 13 churches and had evaluable outcome data were, on average, obese (BMI=33.1 [+/- 7.1]) and had a mean CRP level of 3.7 (+/- 3.9) mg/L. Reductions were observed in waist-to-hip ratio at 3 months (2%, p=0.03) and 1 year (5%, p<0.01). In female participants attending >= 60% of intervention classes, there was a significant decrease in CRP at 3 months of 0.8 mg/L (p=0.05), but no change after 1 year. No differences were noted in BMI or interleukin-6. Conclusions: In overweight/obese, but otherwise healthy, African-American church members with very high baseline CRP levels, this intervention produced significant reductions in CRP at 3 and 12 months, and in waist-to-hip ratio, which is an important anthropometric predictor of overall risk of inflammation and downstream health effects. Trial registration: This study is registered at www.clinicaltrials.gov NCT01760902. (C) 2013 American Journal of Preventive Medicine

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据